Quantcast

Latest pharmaceutical industry Stories

2014-10-06 20:22:39

LONDON, Oct. 6, 2014 /PRNewswire/ -- Pharmaceutical industry is seeing an exponential growth. With changing lifestyle and more and more people being diagnosed with various diseases and increased spending on healthcare by government of different countries world over pharmaceutical has become a multi-billion dollar industry. Pharmaceutical manufacturers must follow stringent requirements to protect consumer safety and environmental regulations. Increasing cost pressures on...

2014-10-06 16:26:39

WASHINGTON, Oct. 6, 2014 /PRNewswire-USNewswire/ -- America's biopharmaceutical research companies are currently developing nearly 800 new medicines and vaccines for cancer, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA). http://photos.prnewswire.com/prnvar/20091027/PHRMALOGO Cancer is the second leading cause of death in the United States, accounting for nearly one of every four deaths, according to the American Cancer...

2014-10-06 12:29:12

The Society for Clinical Research Sites welcomes Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA as its newest Global Impact Partner ELLICOTT CITY, Md., Oct. 6, 2014 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS), the first and only global trade organization fully dedicated to representing the interests of clinical research sites, today announced Merck Sharp & Dohme Corp.'s participation as a Global Impact Partner (GIP), the highest level of membership...

2014-10-06 08:29:39

TORONTO, Oct. 6, 2014 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce that its wholly owned subsidiary, Portage Pharmaceuticals Ltd (PPL) has added the following consultants to its team for further development of its PPL-003 for uveitis and planning for its potential Investigational New Drug (IND) application with FDA. PPL-003 uses a new proprietary cell permeable peptide platform technology...

2014-10-06 08:29:34

NEW YORK and PETACH TIKVAH, Israel, Oct. 6, 2014 /PRNewswire/ -- BrainStorm Cell Therapeutics (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that the last patient has completed the last visit in its phase 2a clinical trial of NurOwn(TM) in Amyotrophic Lateral Sclerosis (ALS), conducted at the Hadassah Medical Center in Jerusalem. The company expects to release final results of the study in the fourth quarter of 2014...

2014-10-06 08:28:55

The real power of the CNPR Certification is that sales professionals learn to communicate with physicians and pharmacists. The CNPR certification was recognized for the award after a rigorous evaluation of the CNPR course's usability and design WASHINGTON, Oct. 6, 2014 /PRNewswire-iReach/ -- The AMA and Pharmaceutical Training Group, Inc. is pleased to announce that the CNPR Certification has been awarded a prestigious E-Learning Courseware award (ECC) by the PRMA Institute. Photo...

2014-10-06 08:28:37

- Lead Product DALVANCE(TM) a Novel Antibiotic for Unmet Medical Need in Hospital and Outpatient Settings - DUBLIN, Ireland and CHICAGO, Oct. 6, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, and Durata Therapeutics, Inc. (NASDAQ: DRTX), an innovative pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses, today announced that they...

2014-10-06 08:28:34

Unilife to be the sole provider of wearable injectors for all of Sanofi's applicable large dose volume drugs YORK, Pa., Oct. 6, 2014 /PRNewswire/ -- Unilife Corporation (NASDAQ: UNIS and ASX: UNS), a developer and supplier of injectable drug delivery systems, announced today the signing of a worldwide Master Services and Commercial Supply Agreement with Sanofi to be the sole provider of cartridge based wearable injectors for all of Sanofi's applicable large dose volume drugs,...

2014-10-06 08:28:31

Collaboration designed to improve and reward medication adherence EXTON, Pa., Oct. 6, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) and HealthPrize Technologies, LLC today announced a strategic collaboration to integrate HealthPrize's Software-as-a-Service (SaaS) medication adherence and patient engagement platform with West's injectable drug delivery systems, to provide an end-to-end connected health solution to pharmaceutical companies and the patients they...

2014-10-06 08:28:05

- Product strengthens growing antiretroviral franchise in the U.S. - PITTSBURGH, Oct. 3, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the U.S. launch of its Lamivudine and Zidovudine Tablets USP, 150 mg/300 mg, which is the generic version of Viiv's Combivir(®). Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment of HIV-1 infection in...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related